🚚 Free Shipping on Orders Over $150 Across Canada 🛡️ Research-Grade Peptides • Laboratory Tested • 99%+ Purity 🔒 Secure Checkout • Fast & Discreet Shipping 🚚 Free Shipping on Orders Over $150 Across Canada 🛡️ Research-Grade Peptides • Laboratory Tested • 99%+ Purity 🔒 Secure Checkout • Fast & Discreet Shipping
What Is Tirzepatide? A Researcher’s Guide to the Dual GIP/GLP-1 Agonist
Tirzepatide for researchers: dual GIP and GLP-1 receptor activity, its GIP-based backbone and lipid chain, and laboratory research questions.
Tirzepatide was designed to activate both major incretin receptors with one molecule. In laboratory research, it is used to investigate how dual GIP and GLP-1 receptor activity compares with single-receptor signalling.
Quick facts
| Property | Detail |
|---|---|
| Length | 39 amino acids |
| Receptor targets | GIPR and GLP-1R |
| Backbone basis | Native GIP sequence, modified |
| Key modification | C20 fatty diacid attached through a linker |
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Research area | Metabolism |
A GIP peptide that also speaks GLP-1
Unlike most GLP-1 research peptides, tirzepatide‘s sequence starts from GIP rather than GLP-1. Selected residues were swapped so it also binds the GLP-1 receptor. The result is an “imbalanced” dual agonist: in receptor assays its potency at GIPR is close to native GIP, while its GLP-1R activity is lower than native GLP-1.
Signalling bias
At the GLP-1 receptor, tirzepatide tends to favour cAMP production over β-arrestin recruitment. This signalling bias is linked in cell studies to less receptor internalisation. It is a key reason the compound is used in pharmacology research on biased agonism.
What laboratories study it for
- cAMP and β-arrestin assays comparing single, dual and triple agonists.
- Receptor trafficking and internalisation studies.
- Preclinical metabolic models alongside semaglutide and retatrutide.
Laboratory documentation and handling
Storage and handling requirements depend on the batch and analytical method. Consult the product documentation, certificate of analysis and your laboratory’s validated procedures. Appearance alone does not establish identity, purity or stability.
Bacteriostatic water is listed in the Lux Peptides laboratory consumables catalogue. Its suitability depends on the requirements of the validated analytical method.
Frequently asked questions
What makes tirzepatide a “dual” agonist?
It activates both the GIP receptor and the GLP-1 receptor.
Is tirzepatide based on GLP-1?
No. Its backbone is derived from GIP, with changes that add GLP-1 receptor activity.
What vial sizes does Lux offer?
Several strengths are listed on the product page; check the COA for each batch.
Sources and further reading
- Coskun et al. (2018) — tirzepatide discovery and receptor pharmacology — Original preclinical and early clinical research.
Related research material
View Tirzepatide at Lux Peptides for the product description and available research formats.
For laboratory research use only. Not for human or veterinary use. Lux Peptides products are not drugs, health products or supplements and are not approved by Health Canada for any therapeutic purpose.
